Amathus Therapeutics
PrivateLast Round
Corporate Funding
Mar 17, 2021
Company Overview
Amathus Therapeutics is a biotechnology company that develops small-molecule therapeutics targeting organelle-specific chaperones for the treatment of neurodegenerative and renal diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amathus Therapeutics Comparables
Compare Amathus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vincere Biosciences | 89% | |
| MitoRx Therapeutics | 81% | |
| Pretzel Therapeutics | 80% |
Amathus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 17, 2021 |
Amathus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sanofi Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2021
Merck & Co., Inc. led the corporate funding round.
Amathus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amathus Therapeutics's valuation, stock price, and market status.
Is Amathus Therapeutics a public or private company?
Amathus Therapeutics is a private company.
What is the current stock price of Amathus Therapeutics?
Amathus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Amathus Therapeutics worth (valuation)?
Valuation information for Amathus Therapeutics is not publicly available.
Can I buy Amathus Therapeutics stock?
Amathus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amathus Therapeutics's last funding round?
Amathus Therapeutics's most recent funding round was Corporate Funding on March 17, 2021.
Who are the main investors in Amathus Therapeutics?
Key investors in Amathus Therapeutics include Sanofi Ventures.
Will Amathus Therapeutics IPO soon?
No public IPO plans have been announced for Amathus Therapeutics.
How can I track Amathus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amathus Therapeutics's secondary market activity and sign up for updates.